Asymmetric dimethylarginine in hematological malignancies: a preliminary study.
about
The autophagic tumor stroma model of cancer: Role of oxidative stress and ketone production in fueling tumor cell metabolismAsymmetric dimethylarginine attenuates serum starvation-induced apoptosis via suppression of the Fas (APO-1/CD95)/JNK (SAPK) pathway.Asymmetric and symmetric dimethylarginines and mortality in patients with hematological malignancies-A prospective study.Basic amino acids and dimethylarginines targeted metabolomics discriminates primary hepatocarcinoma from hepatic colorectal metastases
P2860
Asymmetric dimethylarginine in hematological malignancies: a preliminary study.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Asymmetric dimethylarginine in hematological malignancies: a preliminary study.
@en
Asymmetric dimethylarginine in hematological malignancies: a preliminary study.
@nl
type
label
Asymmetric dimethylarginine in hematological malignancies: a preliminary study.
@en
Asymmetric dimethylarginine in hematological malignancies: a preliminary study.
@nl
prefLabel
Asymmetric dimethylarginine in hematological malignancies: a preliminary study.
@en
Asymmetric dimethylarginine in hematological malignancies: a preliminary study.
@nl
P2093
P2860
P50
P1433
P1476
Asymmetric dimethylarginine in hematological malignancies: a preliminary study
@en
P2093
Angelika Chachaj
Jolanta Antonowicz-Juchniewicz
Justyna Dzietczenia
Kazimierz Kuliczkowski
Ryszard Andrzejak
P2860
P304
P356
10.1080/10428190802510323
P577
2008-12-01T00:00:00Z